Prolonged half-life of voriconazole in a CYP2C19 homozygous poor metabolizer receiving vincristine chemotherapy: Avoiding a serious adverse drug interaction
- Brad Moriyama
- , Oluwaseun Falade-Nwulia
- , Janice Leung
- , Scott R. Penzak
- , Caroline Jjingo
- , Xuan Huang
- , Stacey A. Henning
- , Wyndham H. Wilson
- , Thomas J. Walsh
Research output: Contribution to journal › Letter › peer-review
14
Link opens in a new tab
Scopus
citations